ACDIMA Center for Bioequivalence and Pharmaceutical Studies “ACDIMA BioCenter”, was established in the year 2000, to conduct bioavailability, bioequivalence, clinical,  pharmacokinetics and pharmaceutical studies, in addition to chemical analyses of biological samples. ”Moreover, the BioCenter conducted many bioequivalence studies on various pharmaceutical products, for a number of pharmaceutical factories and companies in the Arab and Foreign Countries. The BioCenter is now accredited by a large number of Arab and International Health Authorities, as it attained the accreditation of the World Health Organization “WHO” and the Turkish and Malaysian Ministries of Health in the past two years, in addition to being a reference center for such studies.From its side, ACDIMA provided continuous support for this project through training and qualifying technical personnel and providing modern equipment and supplies to the Center. The strategic plan of the Center development was also adopted, and a clinical site was set up. Its analytical instruments were also upgraded to comply with the set international standards in this contextof which ACDIMA owns 100%